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Health-Related Quality of Life (HRQL) questionnaires (Q’s) specific to HIV/AIDS were developed 
before the advent of antiretroviral therapy (ART) and/or before current co-formulations which 
have,  purportedly,  a  lower  toxicity  profile. Arguably,  these  Q’s  have diminished  sensitivity  to 
measure  the  current  impact  of  HIV  disease  and  treatment  on  People  Living With  HIV/AIDS 
(PLWHA). Relevant domains important for PLWHA such as sleep, perception of treatment and 
impact of current common side effects, including lipodystrophy are missing and the assessment 
of psycho-social impact could be improved.  
 
The objective is to develop a new Patient-Reported Outcomes (PRO) questionnaire to measure 
the HRQL of PLWHA in different countries and cultures, using an item bank developed from 
semi-directive  interviews  which  explored  the  multidimensionality  of  PLWHA’s  HRQL  with 
participants. To capture cultural differences in perceptions, interviews were held in: Senegal, 
Brazil, USA, Australia, Thailand, China, Cambodia, India and France and recorded, transcribed 
and translated into English and French.  
 
Globally  148  (47%  female)  individuals  consented  to  the  interviews  from  which  the  domains 
representing PRO’s were identified. Using participants’ verbatim, 300 items were generated in 
French  and  English  and  organized  into  a  24-domain  item  bank.  An  endpoint  model  was 
designed to explain the relationship between PRO’s, health status, symptoms, side effects and 
the different domains of HRQL. Cultural differences were identified in domains such as daily 
activities, stigma, and relations with family and/or friends. Cognitive debriefing was carried out at 
each  centre  on  5  participants  not  part  of  the  original  interview  group,  using  a  70  item 
questionnaire  that  had  been  developed—this  was  subsequently  reduced  to  60  items  after 
harmonization. 
 
At the next stage the questionnaire will be administered to 100 participants at each centre. In 
WA the results will be correlated with appropriate clinical information from the WA HIV Cohort 
database. It is anticipated that following psychometric validation and translation into the target 
languages  this  questionnaire  will  be  a  contemporaneous  tool  to  use  with  WA  patients  and 
migrants from high prevalence countries. Globally, the new HRQL instrument will be used by 
those who seek to measure the impact of HIV and treatment on PLWHA accurately. 